Bionano Genomics (BNGO) announced Bionano Symposium 2026, the global event for the optical genome mapping community. This virtual symposium provides a unique platform for researchers to present cutting-edge findings and share insights into emerging applications of OGM technology. Join leading scientists from around the world as they highlight breakthroughs in OGM from February 23-26, 2026. The four-day event will feature presentations from over 30 researchers across North America, Europe, and Asia, covering research applications in hematologic malignancies, solid tumors, bioprocessing, constitutional genetic disorders, and gene and cell therapy. The virtual program includes scientific presentations, interactive panel discussions with Q&A, and a virtual poster hall. “At Bionano, we are transforming the way the world sees the genome,” said Erik Holmlin, president and chief executive officer of Bionano. “Our Symposium brings together the global OGM community to share real-world experiences and demonstrate how OGM can reveal genomic complexity that is difficult to detect with conventional technologies. The 2026 program highlights the expanding role of OGM in oncology research, constitutional genetics, and bioprocessing.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BNGO:
- Bionano Genomics announces publication on OGM, gene editing technology
- Reiterating Buy on Bionano Genomics: Strengthening OGM Adoption and Reimbursement Tailwinds Underpin $7 Price Target
- Bionano Genomics reports preliminary Q4 revenue $7.8M-$8M
- Bionano Genomics recaps advances in OGM showcased at AMP 2025
